Insider · CIK 0002030246
Salomon Azoulay
Files at MBX (MBX Biosciences, Inc.). First filing May 8, 2026, latest Aug 5, 2026.
In brief
Salomon Azoulay files SEC Form 4 as officer at MBX (MBX Biosciences, Inc.). Since May 8, 2026, Salomon Azoulay has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.7M, the latest filed on Aug 5, 2026.
A track record needs three past buys with six months of prices behind them; Salomon Azoulay has 0, so none is measured yet.
The newest scored trade: sold $24k of MBX on Aug 4, 2026, filed Aug 5, 2026, scored 15 (weak). In the last 12 months: 0 buys worth $0 and 3 sells worth $2.7M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MBX: MBX Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | MBXsell MBX Biosciences, Inc. | $24k 370 shares | -3% | +626% from low0% from high | |
| 33Weak | MBX Biosciences, Inc. | $2.7M 70,003 shares | -100% | +321% from low-5% from high | |
| 23Weak | MBX Biosciences, Inc. | $6,824 231 shares | -2% | +230% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 4, 2026 | MBX MBX Biosciences, Inc. | 370 0.00% of outstanding | $24k | Aug 4, 2026 | $2.7M |
| May 8, 2026 | MBX MBX Biosciences, Inc. | 70,003 0.15% of outstanding | $2.7M | May 8, 2026 | $6,825 |
| May 6, 2026 | MBX MBX Biosciences, Inc. | 231 0.00% of outstanding | $6,825 | May 6, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | MBX MBX Biosciences, Inc. | SOpen-market sale Common Stock | -370 | $65.77 | $24k | 14,399 | Aug 5, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +55,000 | $10.46 | $575k | 69,769 | May 11, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -55,000 | $38.38 | $2.1M | 14,769 | May 11, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +15,003 | $16.00 | $240k | 29,772 | May 11, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -15,003 | $38.30 | $575k | 14,769 | May 11, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Stock option (right to buy)derivative10b5-1 | +55,000 | $0.00 | $0 | 194,540 | May 11, 2026 |
| May 8, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Stock option (right to buy)derivative10b5-1 | +15,003 | $0.00 | $0 | 30,008 | May 11, 2026 |
| May 6, 2026 | MBX MBX Biosciences, Inc. | SOpen-market sale Common Stock | -231 | $29.54 | $6,824 | 14,769 | May 8, 2026 |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 15,000 | Feb 3, 2026 |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | AGrant or award Stock option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Feb 3, 2026 |
| Feb 3, 2025 | MBX MBX Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Feb 5, 2025 |
Questions about Salomon Azoulay
Answered from the filings on this page, as of the latest one.
Is Salomon Azoulay buying or selling?
In the last 12 months Salomon Azoulay reported 0 open-market buys worth $0 and 3 open-market sells worth $2.7M on SEC Form 4; the latest was sold $24k of MBX on Aug 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Salomon Azoulay's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Salomon Azoulay has 0.
Where does Salomon Azoulay file Form 4?
Salomon Azoulay has filed Form 4 at MBX (MBX Biosciences, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.